These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31623292)

  • 1. Associations of Cardiovascular and All-Cause Mortality with Metabolic Syndrome in Hemodialysis Patients: A Prospective Single-Center Study.
    Dimitrijevic Z; Jovanovic A; Cvetkovic M; Vrecic T; Kostic E; Mitic B
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31623292
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
    Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
    Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
    Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of metabolic syndrome in midlife in relation to cardiovascular morbidity and all-cause mortality-lessons from a population-based matched cohort study with 27 years follow-up.
    Lönnberg L; Leppert J; Ohrvik J; Rehn M; Chabok A; Damberg M
    BMJ Open; 2024 Sep; 14(9):e081444. PubMed ID: 39284695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease.
    Kang SY; Lee YH; Jeong SJ; Kim JS; Jeong KH; Hwang HS
    Nephrol Dial Transplant; 2024 Apr; 39(5):778-787. PubMed ID: 37791396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, malnutrition, and its associations with cardiovascular and all-cause mortality in hemodialysis patients: Follow-up for three years.
    El Ati Z; Machfar H; Boussafa H; Ati N; Omrane Sioud OB; Zantour B; Bouzidi H; Elati M
    Saudi J Kidney Dis Transpl; 2020; 31(1):129-135. PubMed ID: 32129205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults.
    Yen YF; Hu HY; Lin IF; Lai YJ; Su VY; Pan SW; Ting WY; Su WJ
    Medicine (Baltimore); 2015 Jun; 94(23):e956. PubMed ID: 26061328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological aging mediates the associations of metabolic score for insulin resistance with all-cause and cardiovascular disease mortality among US adults: A nationwide cohort study.
    Li X; Wang J; Zhang M; Li X; Fan Y; Zhou X; Sun Y; Qiu Z
    Diabetes Obes Metab; 2024 Sep; 26(9):3552-3564. PubMed ID: 38853301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the impact of metabolic syndrome components on mortality in older people: A systematic review and meta-analysis.
    Sergi G; Dianin M; Bertocco A; Zanforlini BM; Curreri C; Mazzochin M; Simons LA; Manzato E; Trevisan C
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1452-1464. PubMed ID: 32600955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Moderate-to-Vigorous Physical Activity and the Risk of Major Adverse Cardiovascular Events or Mortality in People With Various Metabolic Syndrome Status: A Nationwide Population-Based Cohort Study Including 6 Million People.
    Park S; Han K; Lee S; Kim Y; Lee Y; Kang MW; Park S; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    J Am Heart Assoc; 2020 Nov; 9(22):e016806. PubMed ID: 33153387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality.
    Chen F; He Y; Wang J; Yu L; Gong Q; Chen Y; An Y; He S; Li G; Zhang B
    J Diabetes; 2024 Aug; 16(8):e13598. PubMed ID: 39155699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral fat distribution versus waist circumference for predicting mortality in metabolic syndrome.
    Wu CJ; Kao TW; Chen YY; Yang HF; Chen WL
    Diabetes Metab Res Rev; 2019 May; 35(4):e3116. PubMed ID: 30548993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Cardiovascular Mortality in Subjects With Metabolic Syndrome Is Largely Attributable to Diabetes and Hypertension in 159,971 Korean Adults.
    Sung KC; Rhee EJ; Ryu S; Kim BJ; Kim BS; Lee WY; Oh KW; Kim YB; Chung PW; Kim H; Byrne CD; Lee KB; Park SW
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2606-12. PubMed ID: 25993638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate dietary energy intake associates with higher prevalence of metabolic syndrome in different groups of hemodialysis patients: a clinical observational study in multiple dialysis centers.
    Duong TV; Wong TC; Chen HH; Chen TW; Chen TH; Hsu YH; Peng SJ; Kuo KL; Liu HC; Lin ET; Wang CS; Tseng IH; Feng YW; Chang TY; Su CT; Yang SH
    BMC Nephrol; 2018 Sep; 19(1):236. PubMed ID: 30231860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality--cohort analysis from the Third National Health and Nutrition Examination Survey.
    Lin JW; Caffrey JL; Chang MH; Lin YS
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4258-67. PubMed ID: 20534759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.